Atlas Trials

Investigating and Characterizing the Immune Response to Prostate Cancer

Clinical trial NCT03331367 · COMPLETED

Trial details

NCT number
NCT03331367
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2017-09-14
Primary completion
2020-02-25
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.